HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Hirai Selected Research

Prostaglandin D2

11/2016Prostaglandin D2 signaling mediated by the CRTH2 receptor is involved in MK-801-induced cognitive dysfunction.
12/2014A deficiency in the prostaglandin D2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation.
1/2014Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation.
8/2013Chemotactic responses of peripheral blood eosinophils to prostaglandin D2 in atopic keratoconjunctivitis.
3/2013Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement.
7/2011Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2.
1/2008Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation.
8/2006Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor.
11/2005Prostaglandin D2 induces chemotaxis in eosinophils via its receptor CRTH2 and eosinophils may cause severe ocular inflammation in patients with allergic conjunctivitis.
1/2004[Prostaglandin D2 in allergy: PGD2 has dual receptor systems].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Hirai Research Topics

Disease

14Inflammation (Inflammations)
01/2019 - 04/2003
8Neoplasms (Cancer)
10/2021 - 07/2007
7Hypersensitivity (Allergy)
07/2016 - 01/2004
4Infections
02/2021 - 09/2008
4Eosinophilia
07/2016 - 03/2005
4Asthma (Bronchial Asthma)
01/2011 - 01/2004
3Diabetic Nephropathies (Diabetic Nephropathy)
07/2020 - 05/2011
3Insulin Resistance
07/2020 - 06/2011
2Lung Diseases (Lung Disease)
03/2022 - 01/2019
2Cystic Fibrosis (Mucoviscidosis)
03/2022 - 06/2019
2Pediatric Obesity
01/2022 - 11/2021
2Hypoglycemia (Reactive Hypoglycemia)
10/2021 - 01/2016
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2020 - 01/2016
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 07/2016
2Diabetes Mellitus
12/2019 - 03/2010
2Fibrosis (Cirrhosis)
01/2019 - 11/2012
2Pneumonia (Pneumonitis)
01/2019 - 03/2013
2Disease Progression
12/2014 - 05/2011
2Atherosclerosis
02/2013 - 03/2010
2Contact Dermatitis (Eczema, Contact)
07/2011 - 08/2006
2Bacterial Infections (Bacterial Infection)
02/2009 - 09/2008
1Insulinoma
10/2021
1Unconsciousness (Loss of Consciousness)
10/2021
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
07/2020
1Hyperemia
01/2020
1Chronic Renal Insufficiency
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
12/2019
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
08/2018
1Precocious Puberty
08/2018
1Adenoma (Adenomas)
08/2018
1Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
08/2018
1Obesity
01/2018
1Leukemia
01/2018
1Knee Osteoarthritis
11/2017
1Hyperaldosteronism (Conn Syndrome)
08/2017
1Autosomal Dominant Polycystic Kidney (ADPKD)
08/2017
1Cognitive Dysfunction
11/2016
1Drug Hypersensitivity (Drug Allergy)
04/2016

Drug/Important Bio-Agent (IBA)

10Prostaglandin D2IBA
11/2016 - 01/2004
10Prostaglandins DIBA
11/2012 - 08/2003
7Insulin (Novolin)FDA Link
07/2020 - 02/2013
6ProstaglandinsIBA
01/2011 - 04/2003
5prostaglandin D2 receptorIBA
01/2019 - 08/2006
5Immunoglobulin E (IgE)IBA
04/2016 - 01/2004
4Pharmaceutical PreparationsIBA
03/2022 - 01/2012
3Proteins (Proteins, Gene)FDA Link
02/2021 - 11/2010
3AllergensIBA
04/2016 - 01/2008
3ramatrobanIBA
05/2015 - 03/2005
3Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
12/2014 - 08/2006
3AdiponectinIBA
02/2013 - 05/2011
3Toll-Like Receptor 2IBA
03/2010 - 09/2008
2Sodium-Glucose Transport ProteinsIBA
03/2022 - 01/2020
2Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
03/2022 - 06/2019
2Glucose (Dextrose)FDA LinkGeneric
10/2021 - 01/2016
2Hemoglobins (Hemoglobin)IBA
01/2021 - 07/2020
2LipopolysaccharidesIBA
05/2015 - 02/2014
2Carboplatin (JM8)FDA LinkGeneric
11/2014 - 01/2012
2Interleukin-4 (Interleukin 4)IBA
11/2012 - 04/2008
2Biomarkers (Surrogate Marker)IBA
01/2012 - 09/2008
2Interleukin-5 (Interleukin 5)IBA
04/2008 - 03/2005
1CotinineIBA
01/2022
1Tobacco Smoke Pollution (Passive Smoking)IBA
11/2021
1Diazoxide (Hyperstat)FDA Link
10/2021
1lanreotide (Somatuline)FDA Link
10/2021
1pentetreotide (OctreoScan)FDA Link
10/2021
1Type III Secretion SystemsIBA
01/2021
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
07/2020
1AlbuminsIBA
01/2020
1ipragliflozinIBA
01/2020
1CreatinineIBA
01/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2019
1Lipoproteins (Lipoprotein)IBA
12/2019
1Sitagliptin Phosphate (Januvia)FDA Link
12/2019
1anagliptinIBA
12/2019
1LDL CholesterolIBA
12/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2019
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2019
1CollagenIBA
01/2019
1myocardinIBA
01/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1GATA5 Transcription FactorIBA
01/2018
1MEF2 Transcription FactorsIBA
01/2018
1Iodoacetic AcidIBA
11/2017
1Prostaglandins AIBA
11/2017
1AldosteroneIBA
08/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2016
1Cyclooxygenase 1IBA
11/2016
1Dizocilpine Maleate (Dizocilpine)IBA
11/2016
1EnzymesIBA
11/2016
1Glucagon-Like Peptide 1 (GLP 1)IBA
07/2016
1LiraglutideFDA Link
07/2016
1Insulin AntibodiesIBA
07/2016
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2016
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2016

Therapy/Procedure

4Therapeutics
10/2021 - 10/2007
2Adrenalectomy
08/2018 - 08/2017
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2014 - 01/2014
1Intra-Articular Injections
11/2017